Homeopathic remedy for stabilization of visual function in glaucoma with normalized intraocular pressure

 

(57) Abstract:

The invention relates to the creation of homeopathic remedies and can be used in the conservative treatment of glaucoma with medication or surgically normalized and normal intraocular pressure. Suggested homeopathic remedy for stabilization of visual function in glaucoma with normalized intraocular pressure containing Gelsemium, Ammonium carbonicum, Carbo vegetabilis, taken in equal proportions during the next breeding ingredients: Gelsemium C3, Ammonium carbonicum C3, Carbo vegetabilis C6. In addition, it can optionally contain Aurum iodatum in breeding C6 and/or Acidum phosphoncum in breeding C6, this homeopathic remedy is made in the form of sugar granules. This tool is used in all age groups of patients, including in geriatric practice. 3 C.p. f-crystals.

The invention relates to medicine, namely to ophthalmology and homeopathy, and can be used in the conservative treatment of glaucoma with medication or surgically normalized and normal intraocular pressure (IOP).

More than half of the patients with glaucoma with normalized drug or microsurgically IOP PR is m and low IOP is also observed progressive course of glaucomatous process. The treatment of these groups of patients is one of the most important problems of modern ophthalmology. Therefore, the development of new or improvement of existing drugs for the stabilization of visual function in glaucoma with normal or normalized IOP is an important task.

It is known the use of Gelsemium in the treatment of glaucoma (Homeopathy. Complete encyclopedia / Ed. A. N. Alferov. - SPb.: ID "WHOLE", 2001. S. 337).

However this drug is not effective to stabilize visual function in glaucoma.

The aim of the invention is the creation of a complex homeopathic remedy for stabilization of visual function in glaucoma with normalized intraocular pressure, improving the treatment of glaucoma.

This objective is achieved in that the tool contains Gelsemium, Ammonium carbonicum, Carbo vegetabilis, taken in equal proportions during the next breeding components:

Gelsemium C3

Ammonium carbonicum C3

Carbo vegetabilis C6

The tool may further comprise Aumm iodatum in breeding C6, and Acidum phosphoricum in breeding C6.

Comparative analysis of the prototype showed that the proposed tool is different from the known fact that the tool Soderini way the proposed solution meets the criteria of the invention of “novelty.”

The analysis of patent literature showed that the proposed homeopathic remedy differs not only from the prototype, but also on other technical solutions in this and related fields. So the authors have not found homeopathic complexes proposed composition for the stabilization of visual function in glaucoma treatment. Namely, the proposed structure allows it to achieve its goal: to create a complex homeopathic remedy is effective in the treatment of glaucoma with normalized or normal IOP. Homeopathic complex allows to improve the condition of the vascular system, cell and tissue respiration, improve blood flow in the optic nerve and the retina and slow down the progression of glaucoma. The tool increases the adaptive capabilities of the regulatory systems of homeostasis of the body (neuro-humoral, metabolic, blood vessels). He has a modulating effect on antioxidant activity.

Thus, the reception means normalizes metabolism, microcirculation, improves trophic tissues. The complex action of the tool allows Powys the x pharmacies.

Thus, this solution meets the criteria of “inventive step” and “industrial applicability”.

The proposed product contains medicinal substances prepared according to the method of homeopathy, and neutral media. As a medicinal substances the product contains Gelsemium, Ammonium carbonicum, Carbo vegetabilis, taken in equal proportions during the next breeding components:

Gelsemium C3

Ammonium carbonicum C3

Carbo vegetabilis C6

Additionally, the tool may further comprise Aurum iodatum in breeding C6 and Acidum phosphoricum in breeding C6. Means prepared in the form of sugar granules.

Take the tool for 5-7 pellets (resolve), 15-20 minutes before meals, 2 times a day. The tool containing Gelsemium, Ammonium carbonicum, Carbo vegetabilis (basic composition), as well as, optionally containing Aurum iodatum, take 2-3 months 2-3 times a year as monotherapy or in combined treatment with other agents. The course may be repeated 2-3 times a year. In glaucoma, the pathogenesis of which play an important role in functional changes of blood vessels, apply the tool with the base composition. In glaucoma pathogenesis of which appear along with the functional organic changes of the vessels (the accept within 1 month. Treatment in this case, start the tool with a base composition or additionally containing Aurum iodatum, and in the last month of treatment, take the tool, optionally containing Acidum phosphoricum.

The effectiveness of the proposed treatment homeopathic remedy was evaluated by the dynamics of visual functions - Central and peripheral vision.

Example 1. B-th L., 48 years old.

Ds: I open And glaucoma OD. Osteochondrosis of the cervical spine.

Vis OD of 0.7 is not Corr

OS 1,0

IOP: OD 21 mm RT. Art. (in the background instillation of 0.5% solution of timolol 2 times per day)

OS 19 mm RT. senior Perimetry:

OD: the boundaries of the peripheral visual field is normal. In the paracentral region scotomas I-III level: scotomas I level 3,9%, level II - 3.3%, and the absolute value of 1.3%, a normal area of the field of view is 91.5%.

OS: peripheral and Central visual field is normal.

The transparent lenses.

The fundus of the eye: OD: optic nerve pink, clear boundaries, physiological excavation extended, the ratio e/D=0,6

OS: eyeground in norm. The ratio e/D=0,4

Assigned: continue instillation of 0.5% solution of timolol 2 times a day right eye. Trental 0.1 g Complaints reduced distance vision in his right eye.

Objectively:

Vis OD of 0.6 is not Corr

OS 1,0

IOP: OD 20 mm RT. Art. (in the background instillation of 0.5% solution of timolol 2 times a day).

OS 19 mm RT. Art.

Perimetry:

OD: increased number paracentral scotomas: scotomas level I amounted to 4.6%, level II - 5.2 percent. Absolute scotoma was 2%. Normal areas of the field of view - 88,2%.

OS: Central and peripheral field of vision is normal.

Ds: I Open And glaucoma OD, unstabilized over.

Osteochondrosis of the cervical spine.

Appointed: instillation of 0.5% solution of timolol 2 times a day in both eyes. Receiving homeopathic remedies 5 pellets 2 times a day 20 minutes before meals for 2 months. During the 1st month of treatment the patient has a tool that includes Gelsemium, Ammonium carbonicum, Carbo vegetabilis, at the above dilutions, and during the 2-month - tool, optionally containing Acidum phosphoricum when breeding C6.

After 3 months on check:

Complaints to further decrease the distance vision does not show.

Objectively:

Vis OD of 0.7 is not Corr

OS 1,0

IOP OD 21 mm RT. Art. (in the background instillation of 0.5% solution of timolol 2 times per day)

OS 20 mm RT. with the,0%, Level II is 1.3%. Absolute scotoma was 1.3%. Normal areas of the field of view of 95.4%.

OS: peripheral and Central visual field is normal.

OD: the Ratio e/D=0,6

OS: the ratio e/D=0,4

Thus, after a course of treatment that includes the taking of homeopathic complex, improvement of visual functions (increased visual acuity, decreased the number of relative and absolute scotomas in the visual field OD).

The patient took the offered complex 2-3 times per year for 2 months. During the observation period (2 years) deterioration of visual function has not happened: there has been a stabilization of the glaucomatous process.

Example 2. B.-K. Oh, and 65 years.

Ds: open-angle glaucoma II-A in both eyes.

Hypertension of I degree.

Atherosclerosis of cerebral vessels.

Objectively:

Vis OD of 0.5 sph+1,0=0,6

OS 0,6 sph+1,0-0,7

IOP (in the background instillation of 1% solution of practolol 2 times a day in both eyes):

OD 20 mm RT. Art.

OS 22 mm RT. Art.

In the study fields of view obtained the following results:

OD: narrowing of the peripheral field of vision from the nasal side 10. Scotomas level I amounted to 20.9%, level II - 13%.

Abs is the field of view from the nasal side 15. Scotomas first level was 17.6%, second - 5.2%, and the absolute is 6.6%. Normal areas of the field of view was $ 70.6%.

The lens is transparent.

The fundus of the eye:

OU: the optic nerve disc pink, clear boundaries, glucosamina excavation optic nerve disc, the ratio e/D=0,8. Vascular wall of the arteries hardened, Salus II.

The macular region without pathology.

Appointed: mode instillation of a solution of practolol the same. Piracetam on 0,4 g 3 times a day, nikoshpana 1 tab. 3 times a day orally for 2 months.

After 3 months on check:

Vis OD of 0.5 sph+1,0=0,6

OS 0,6 sph+1,0=0,7

IOP (in the background instillation of 1% solution of practolol 2 times a day in both eyes):

OD 20 mm RT. Art.

OS 21 mm RT. Art.

The fundus of the eye:

OU: Extensions glaucomatous excavation of the optic nerve disc no, the ratio e/D=0,8.

Perimetry:

OD: narrowing of the peripheral field of vision from the nasal side 10. Scotomas level I amounted to 15%, level II - 24,8%. Absolute scotomas amounted to 5.9%. Normal areas of the field of view or 54.3%.

OS: narrowing of the peripheral field of view with the bow hand 15. Scotomas first level was 21.6%, second to 10.5%, the absolute of 7.8%. Normal areas of the field of view is th - the reduced visual acuity, increasing the number of cattle in the visual fields of both eyes.

Ds: open-angle glaucoma II-A in both eyes, unstabilized over.

Appointed: instillation of a 1% solution of practolol in the same mode, reception of homeopathic complex for the stabilization of visual functions 7 pellets for 15 minutes before meals, 2 times a day for 3 months. During the first two months of treatment, the patient is assigned to a tool, comprising Gelsemium, Ammonium carbonicum, Carbo vegetabilis, Aurum iodatum at the above dilutions, and during the third month of treatment - tool, optionally containing Acidum phosphoricum when breeding C6.

After 3 months on check:

Vis OD of 0.5 sph+1,0=0,7

OS 0,6 sph+1,0=0,7

IOP (in the background instillation of a 1% solution of practolol 2 times a day in both eyes):

OD 20 mm RT. Art.

OS 20 mm RT. Art.

Perimetry:

OD: narrowing of the peripheral field of vision from the nasal side by 5. Scotomas level I amounted to 15.7%, level II - 9.2 percent. Absolute scotoma was 4.6%. Normal areas of the field of view 70,6%.

OS: narrowing of the peripheral field of vision from the nasal side 10. Scotomas first level was 11.8%, a second - 3,9%, the absolute level of 5.2%. Normal ucati visual function - expanded the boundaries of the peripheral visual field of the right and left eyes, decreased the number of relative and absolute scotomas in the visual fields of both eyes, increased visual acuity OS.

The patient took the offered tool 2-3 times a year for 3 months as monotherapy or in combination with other treatments. During the observation period (3 years) deterioration of visual acuity, changes the field of view (having more cattle, narrow down the field of view) was not. Thus, the proposed tool has helped to stabilise the visual function.

We offer homeopathic remedy used in the treatment of glaucoma in 42 patients (56 eyes), including those with functional changes in the vessels 20 people (30 eyes) with organic changes of the vessels (angiosclerosis) - 22 (26 eyes).

All patients before treatment, we offer a homeopathic remedy received medical treatment of vascular drugs (nicotinic acid, nikoshpana, piracetam and so on). The IOP ranged from 18 to 24 mm RT. senior, averaging 21,21,5 mm RT. Art. the Progression of glaucomatous process in these patients was confirmed by the results of the dynamic observation within 1.5 s of the excavation of the optic nerve, deterioration of visual acuity.

Patients received a proposed package within 2-3 months 2-3 times a year. It was noted stabilization of visual functions (preservation of visual acuity, lack of progression of the narrowing of the boundaries of the peripheral field of view, the appearance of additional cattle in the Central field of view) in 16 patients (23 eyes) people of the first group (76,6%) and 16 men (19 eyes) (73.1 per cent) of the second group during the observation period (2-3 years).

Thus, the proposed homeopathic remedy makes it possible to stabilize visual function in patients with normal IOP, reduce vascular-venous disorders in the optic nerve and the retina.

This tool for the treatment of glaucoma has a complex effect on the body and so is quite versatile. In this regard, it can be prescribed by a doctor, not having a special homeopathic knowledge. When this tool is available, has no contraindications for use, does not produce allergic reactions, may be combined with administration of other drugs or used in monotherapy. The proposed tool can be used in all age groups of patients, including in geriatricians intraocular pressure, containing Gelsemium, characterized in that it further comprises Ammonium carbonicum, Carbo vegetabilis, taken in equal proportions during the next breeding components:

Gelsemium C3

Ammonium carbonicum C3

Carbo vegetabilis C6

2. Homeopathic remedy under item 1, characterized in that it further comprises Aurum iodatum in breeding C6.

3. Homeopathic remedy for PP.1 and 2, characterized in that it further comprises Acidum phosphoricum in breeding C6.

4. Homeopathic remedy for PP.1-3, characterized in that it is made in the form of sugar granules.

 

Same patents:

The invention relates to imidazole derivative of the formula (I), where X, Y, R, R2, R3and R4such as defined in the claims

The invention relates to imidazole derivative of formula (1), where X, Y, R, R2, R3and R4such as defined in the claims

The invention relates to the field of medicine and relates to a composition for topical application, reducing intraocular pressure, comprising the antagonist of angiotensin II, boric acid and ethylenediaminetetraacetic acid

The invention relates to the field of medicine and organic chemistry and relates to new derivatives of prostaglandin F-type used as an ocular hypotensive drugs, as well as to a method of treatment of glaucoma with their help, ophthalmic solutions and kits comprising these solutions

The invention relates to new indole derivative of the formula I

< / BR>
where R denotes ethyl or 2,2,2-triptorelin group; Y is hydroxy or pivaloyloxy; the carbon atom marked with the symbol (R) is the carbon atom in (R)-configuration, or its pharmaceutically acceptable salts

The invention relates to medicine, namely to ophthalmology, and for the treatment of patients with open-angle glaucoma with normalized intraocular pressure

The invention relates to the field of ophthalmology

The invention relates to new guanidinium heterocyclic compounds of the formula (I), where R1denotes H, alkyl or is absent when R1missing link (a) is a double bond, D represents CR2, R2selected from H, alkyl, halogen, or, when is a CR3D can be N, denotes NR9, CR3=CR8, CR3, S, where R9denotes H, alkyl, alkenyl or quinil and where R3and R8selected from H, alkyl, alkenyl, quinil or cyano, R4, R5, R6each independently selected from H, alkyl, alkenyl, quinil, cyano, halogen or NH-C(= NR10)OTHER11(guanidine), R10and R11selected from H, methyl and ethyl, and where only one of R1, R5and R6is guanidines, R7selected from H, alkyl, alkenyl, quinil and halogen
The invention relates to medicine, in particular to ophthalmology, and for the health of the retina and optic nerve in various pathologies of the eye
The invention relates to medicine, in particular to neuropathology and treatment of neurological manifestations of osteochondrosis physical factors, and can be used in hospitals, clinics, sanatoria, preventoria, home
The invention relates to medicine, in particular to neuropathology and treatment of neurological manifestations of osteochondrosis physical factors, and can be used in hospitals, clinics, sanatoria, preventoria, home

The invention relates to medicine, in particular to urology, andrology

The invention relates to the field creating means having an antimicrobial effect on local purulent-inflammatory processes of the soft tissues

The invention relates to medicine and pharmaceutical industry and for the manufacture of dosage forms of enterosorbents

The invention relates to pharmaceutical and food industry and can be used for the prevention and treatment of iodine deficiency diseases
The invention relates to medicine, in particular, to obstetrics
The invention relates to medicine, in particular, to obstetrics

FIELD: medicine.

SUBSTANCE: method involves preparation dental surface, covering it with 30% aqueous solution of silver nitrate and recovery agent for precipitating insoluble silver salts. Silver salts precipitation is carried out by exposing silver nitrate covering tooth surface with halogen radiation of the kind produced by halogen lamp of 12 W or 75 W having spectral bandwidth of 400…500 nm provided with light guide for concentrating luminous flux for 60 s.

EFFECT: enhanced effectiveness of treatment; localized treatment; reduced risk of complications and stress action upon child.

Up!